Evidence map›Paper›PMID 33458569›Full record

ArticleSN comprehensive clinical medicine2021

Re-reading ACT, BCG, and Low COVID-19 in Africa.

Jia Bainga Kangbai, Lawrence Sao Babawo, Daniel Kaitibi, Anthony A Sandi, Angela Magdalene George, Foday Sahr

Open access · bronzeAbstract read
In one paragraph

Article in SN comprehensive clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2022
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jia Bainga KangbaiCenter for International Health, University of Munich (LMU), Munich, Germany.ORCID 0000-0002-3093-8943
Lawrence Sao BabawoThe National COVID Emergency Response Centre (NACOVERC), Freetown, Sierra Leone.
Daniel KaitibiNjala University, Freetown, Sierra Leone.
Anthony A SandiMinistry of Health and Sanitation, Freetown, Sierra Leone.
Angela Magdalene GeorgeDepartment of Nursing, Njala University, Freetown, Sierra Leone.
Foday SahrThe National COVID Emergency Response Centre (NACOVERC), Freetown, Sierra Leone.
Njala University · SLMinistry of Health and Sanitation · SLUniversity of Sierra Leone · SL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

October 11, 2020, marks the seventh month since the World Health Organization (WHO) officially declared COVID-19 a pandemic. Unlike other coronavirus diseases, there is a geographically disproportionate distribution of the incidence of COVID-19 cases around the world. We observed a significantly high COVID-19 cases and deaths in countries and territories with no or very small number of malaria cases or no or low national TB cases in 2018. We speculate that the high incidence of COVID-19 cases and deaths in countries less affected by malaria is partly due to overexposure to malaria which led to the regular use of the artemisinin anti-malaria drugs as well as the regular use of bacillus Calmette-Guérin (BCG) vaccine for TB prevention. The vaccine produced an almost life-long immunity to TB and meningitis to its recipients. We are thus calling for a COVID-19 containment and clinical management protocol that will incorporate the use of the anti-malaria ACT drug cocktail and BCG vaccine on compassionate ground.

Indexed as

ArtemisininCoronavirusCOVID-19IncidenceMalariaPandemicTuberculosis

Identifiers

PMID33458569
PMCPMC7801564
OpenAlexW3118889027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.